- news, features, articles and disease information for the swine industry


First HIPRA SENG Vaccine Reaches China

24 June 2015
Hipra - Suiseng with Hipramune - Experience a new type of immunity!

CHINA - Last April, HIPRA presented RHINISENG®, the innovative vaccine for the prevention of Progressive and Non- progressive Swine Atrophic Rhinitis, in China.

RHINISENG® also offers the perfect balance between safety and efficacy thanks to its exclusive new-generation ginsenoside-based adjuvant (HIPRAMUNE® Gd).

For the occasion, HIPRA brought together four national and international experts in pig production: Dr Guangzhi Tong (China), Dr Fangzhen Wu (China), Dr Enric Marco (Spain) and Dr Marten de Jong (Holland).

Specialists from throughout the country attended the event, which gave them the opportunity to update their knowledge on future developments and trends in pig production in China and internationally, as well as on the control of different diseases, keeping the focus on Atrophic Rhinitis.

The RHINISENG® logo, sculpted in ice, closed the event which was co-ordinated by Rong Yu Zeng (Technical and Marketing Manager, HIPRA CHINA) and attended by Rafael Pedrazuela (Swine Business Unit Manager, HIPRA) and Alba Martos (Rhiniseng® Product Manager, HIPRA).

With the launch of RHINISENG® in China, HIPRA is continuing its global expansion and consolidation, specifically on the continent of Asia, as the reference in prevention for animal health.

ThePigSite News Desk

Share This

News By

Related News


News from European Union  30 May 2018

More News

EU pig prices under pressure

News from European Union   21 November 2018

Our Sponsors


Seasonal Picks

Animal Welfare Science, Husbandry and Ethics: The Evolving Story of Our Relationship with Farm Animals - 5m Books